Literature DB >> 20378934

Common aberrations from the normal human plasma N-glycan profile.

Maja Pucic1, Sofia Pinto, Mislav Novokmet, Ana Knezevic, Olga Gornik, Ozren Polasek, Kristian Vlahovicek, Wei Wang, Pauline M Rudd, Alan F Wright, Harry Campbell, Igor Rudan, Gordan Lauc.   

Abstract

After performing hydrophilic interaction and weak anion exchange high-performance liquid chromatography to analyze N-glycans in the plasma of 1991 people, we identified several individuals that differed significantly from the "normal" profile of N-glycans. By performing consensus scoring of pairwise distances between vectors containing measured glycan values, we formed six groups of individuals with specific glyco-phenotypes. Some aberrations from the normal plasma protein patterns were found to be associated with clinical conditions (such as renal problems in people with increased monosialylated biantennary glycans, A2G2S1), while other substantial changes in N-glycan structure, such as the near complete absence of neutral glycans or antennary fucosylated tri- and tetraantennary glycans, were not associated with any observed adverse health outcomes. These results demonstrate the existence of specific altered glyco-phenotypes in some individuals and indicate that in some cases they might represent risk factors for the development of specific diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378934     DOI: 10.1093/glycob/cwq052

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  18 in total

1.  Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders.

Authors:  Nela Pivac; Ana Knezević; Olga Gornik; Maja Pucić; Wilmar Igl; Hilde Peeters; An Crepel; Jean Steyaert; Mislav Novokmet; Irma Redzić; Matea Nikolac; Vesna Novković Hercigonja; Katarina Dodig Curković; Mario Curković; Gordana Nedić; Dorotea Muck-Seler; Fran Borovecki; Igor Rudan; Gordan Lauc
Journal:  Mol Cell Proteomics       Date:  2010-10-25       Impact factor: 5.911

Review 2.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

3.  Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.

Authors:  Zhenxin Lin; Diane M Simeone; Michelle A Anderson; Randall E Brand; Xiaolei Xie; Kerby A Shedden; Mack T Ruffin; David M Lubman
Journal:  J Proteome Res       Date:  2011-03-31       Impact factor: 4.466

Review 4.  Characterization of isomeric glycan structures by LC-MS/MS.

Authors:  Lucas Veillon; Yifan Huang; Wenjing Peng; Xue Dong; Byeong Gwan Cho; Yehia Mechref
Journal:  Electrophoresis       Date:  2017-05-17       Impact factor: 3.535

5.  The N-glycome of human plasma.

Authors:  Katherine A Stumpo; Vernon N Reinhold
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

6.  Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Chang-Hong Yi; Hong-Lei Weng; Fei-Guo Zhou; Meng Fang; Jun Ji; Cheng Cheng; Hao Wang; Roman Liebe; Steven Dooley; Chun-Fang Gao
Journal:  Oncoimmunology       Date:  2015-07-07       Impact factor: 8.110

7.  Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.

Authors:  Gordan Lauc; Abdelkader Essafi; Jennifer E Huffman; Caroline Hayward; Ana Knežević; Jayesh J Kattla; Ozren Polašek; Olga Gornik; Veronique Vitart; Jodie L Abrahams; Maja Pučić; Mislav Novokmet; Irma Redžić; Susan Campbell; Sarah H Wild; Fran Borovečki; Wei Wang; Ivana Kolčić; Lina Zgaga; Ulf Gyllensten; James F Wilson; Alan F Wright; Nicholas D Hastie; Harry Campbell; Pauline M Rudd; Igor Rudan
Journal:  PLoS Genet       Date:  2010-12-23       Impact factor: 5.917

8.  Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.

Authors:  Michael C Carlsson; Cecilia Cederfur; Viveka Schaar; Crina I A Balog; Adriana Lepur; Franck Touret; Emma Salomonsson; André M Deelder; Mårten Fernö; Håkan Olsson; Manfred Wuhrer; Hakon Leffler
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

9.  Evolutional and clinical implications of the epigenetic regulation of protein glycosylation.

Authors:  Tomislav Horvat; Vlatka Zoldoš; Gordan Lauc
Journal:  Clin Epigenetics       Date:  2011-06-14       Impact factor: 6.551

10.  Reversibility of membrane N-glycome of HeLa cells upon treatment with epigenetic inhibitors.

Authors:  Tomislav Horvat; Martina Deželjin; Irma Redžić; Darko Barišić; Maja Herak Bosnar; Gordan Lauc; Vlatka Zoldoš
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.